Human IL-21, Fc Tag (Cat. No. IL1-H5253) stimulates secretion of IFN-gamma by NK-92 human natural killer lymphoma cells. The EC50 for this effect is 0.94-1.34 μg/mL (Routinely tested).
Immobilized Human IL-21 R, Fc Tag (Cat. No. ILR-H5257) at 5 μg/mL (100 μL/well) can bind Biotinylated Human IL-21, Fc,Avitag (Cat. No. IL1-H82F7) with a linear range of 1-10 ng/mL (QC tested).
Immobilized Human IL-21 R, His Tag (Cat. No. ILR-H5226) at 2 μg/mL (100 μL/well) can bind Human IL-21, Fc Tag (Cat. No. IL1-H5253) with a linear range of 0.2-8 ng/mL (QC tested).
Interleukin-21 (IL-21) is a secreted protein which belongs to the IL-15 / IL-21 family. Interleukin-21 / IL-21 belongs to a family of cytokines that bind to a composite receptor consisting of a private receptor (IL21R) and the common cytokine receptor gamma chain (gamma(C)). Interleukin-21 / IL-21 impacts a number of cell types, including CD8+ memory T cells, NK cells and subsets of CD4 memory T cells. The IL-21R is widely distributed on lympho-haematopoietic cells. IL-21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. IL-21 promotes the anti-tumor activity of CD8+ T-cells and NK cells. IL-21 exerts its effect through binding to a specific type I cytokine receptor, IL-21R, which also contains the ¦Ã chain (¦Ãc) found in other cytokine receptors including IL-2, IL-4, IL-7, IL-9 and IL-15. The IL-21/IL-21R interaction triggers a cascade of events which includes activation of the tyrosine kinases JAK1 and JAK3, followed by activation of the transcription factors STAT1 and STAT3.